Manon Fernet and her company 7734956 CANADA, doing business as Freedom Center Against Obesity, have agreed to pay $500,000 to the U.S. Federal Trade Commission (FTC) to settle charges that they deceived customers by claiming that their product, Double Shot pills, would cause substantial weight loss quickly and without diet and exercise changes. FTC v. 7734956 CANADA, No. 14-2267 (U.S. Dist. Ct., Md., N. Div., order entered July 21, 2014).
Through its direct advertising, the company claimed that Double Shot users could eat plates of food and absorb only a fraction of the calories by taking a blue pill that burned fat and a red pill that blocked calories. It purported to support these claims through the endorsement of a doctor who served as the director of weight loss research at the Freedom Center Against Obesity, the name the company gave to its fulfillment house. In addition to the $500,000 payment, the settlement requires the defendants to document in detail any studies conducted to support their health claims, and it enjoins them from manufacturing or selling weight loss products, making misleading claims about Double Shot pills or misrepresenting scientific study results.